Proseek Bio Advances to Phase 2 of the BioTools Innovator 2026 Program

We’re pleased to share that Proseek Bio has been selected to advance to Phase 2 of the BioTools Innovator 2026 program.

Out of more than 500 global applicants, only the top 15% have been invited to this stage. Being included in this cohort is a strong validation of the work our team is doing to advance diagnostic innovation.

What is BioTools Innovator?

BioTools Innovator is a leading accelerator program for life science tools companies, bringing together a global network of investors, strategic partners, and industry experts. The program is designed to support high-potential companies developing technologies that can shape the future of life sciences.

Advancing to Phase 2 includes an invitation to pitch in person as part of the BioTools Innovator Road Tour, taking place in San Diego this April.

Looking Ahead to San Diego

As part of the Road Tour, we’ll have the opportunity to present our work to multiple panels of investors, operators, and strategic leaders across the life sciences ecosystem. Beyond the pitch sessions, the program also creates space for meaningful conversations and potential collaborations with others building in this space.

We’re looking forward to sharing what we’re building at Proseek Bio, and to connecting with peers and partners who are equally focused on advancing the next generation of life science tools.

A Step Forward in Our Journey

This milestone comes at an exciting time for the company, as we continue to progress our platform and expand our global engagement.

We’re proud to be part of a cohort of companies pushing the boundaries of innovation in life sciences — and we’re excited for what’s ahead.